Collplant Biotechnologies Ltd
NASDAQ:CLGN

Watchlist Manager
Collplant Biotechnologies Ltd Logo
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Watchlist
Price: 1.375 USD -5.5% Market Closed
Market Cap: 15.7m USD

Wall Street
Price Targets

CLGN Price Targets Summary
Collplant Biotechnologies Ltd

Wall Street analysts forecast CLGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLGN is 14.28 USD with a low forecast of 14.14 USD and a high forecast of 14.7 USD.

Lowest
Price Target
14.14 USD
928% Upside
Average
Price Target
14.28 USD
939% Upside
Highest
Price Target
14.7 USD
969% Upside
Collplant Biotechnologies Ltd Competitors:
Price Targets
LGND
Ligand Pharmaceuticals Inc
30% Upside
EDIT
Editas Medicine Inc
53% Upside
BIOCON
Biocon Ltd
10% Upside
ALNY
Alnylam Pharmaceuticals Inc
3% Upside
TNG
Transgene SA
97% Upside
688520
Sinocelltech Group Ltd
5% Downside
BMRN
Biomarin Pharmaceutical Inc
78% Upside
4BB
4Basebio PLC
76% Upside

Revenue
Forecast

Revenue Estimate
Collplant Biotechnologies Ltd

For the last 5 years the compound annual growth rate for Collplant Biotechnologies Ltd's revenue is -26%. The projected CAGR for the next 3 years is 156%.

-26%
Past Growth
156%
Estimated Growth
Estimates Accuracy
-15%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Collplant Biotechnologies Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
Collplant Biotechnologies Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CLGN's stock price target?
Price Target
14.28 USD

According to Wall Street analysts, the average 1-year price target for CLGN is 14.28 USD with a low forecast of 14.14 USD and a high forecast of 14.7 USD.

What is Collplant Biotechnologies Ltd's Revenue forecast?
Projected CAGR
156%

For the last 5 years the compound annual growth rate for Collplant Biotechnologies Ltd's revenue is -26%. The projected CAGR for the next 3 years is 156%.

Back to Top